Funds and ETFs electroCore, Inc.

Equities

ECOR

US28531P2020

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 02:00:01 04/05/2024 am IST 5-day change 1st Jan Change
6.325 USD +3.35% Intraday chart for electroCore, Inc. +9.81% +6.27%
electroCore, Inc. is a commercial stage bioelectronic medicine and wellness company. It provides non-invasive vagus nerve stimulation (nVNS) technology platform. The Company’s product categories include Handheld, personal use medical devices for the management and treatment of certain medical conditions such as primary headache, and Handheld, personal use consumer products utilizing nVNS technology to promote general wellness and human performance. Its products include gammaCore, Truvaga and TAC-STIM. Its gammaCore Sapphire, is a prescription medical device that is used for a variety of primary headache conditions. Its Truvaga is a personal use consumer electronics general wellness product that does not require a prescription and is available direct-to-consumer from electroCore at www.truvaga.com. The Company’s TAC-STIM product is not a medical device and is not intended to diagnose, cure, mitigate, prevent, or treat a disease or condition.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
6.325 USD
Average target price
23.1 USD
Spread / Average Target
+265.22%
Consensus
  1. Stock Market
  2. Equities
  3. ECOR Stock
  4. Funds and ETFs electroCore, Inc.